Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-5.64 Insider Own32.72% Shs Outstand29.65M Perf Week-2.35%
Market Cap618.83M Forward P/E- EPS next Y-0.76 Insider Trans-0.30% Shs Float20.04M Perf Month-9.85%
Income-167.82M PEG- EPS next Q-0.32 Inst Own48.65% Short Float3.01% Perf Quarter-26.02%
Sales289.21M P/S2.14 EPS this Y-158.27% Inst Trans1.30% Short Ratio2.82 Perf Half Y-18.25%
Book/sh38.31 P/B0.54 EPS next Y28.66% ROA-12.39% Short Interest0.60M Perf Year-31.76%
Cash/sh14.24 P/C1.46 EPS next 5Y- ROE-13.97% 52W Range20.66 - 44.09 Perf YTD-28.12%
Dividend Est.- P/FCF128.92 EPS past 5Y-78.39% ROI-14.65% 52W High-52.87% Beta1.42
Dividend TTM- Quick Ratio6.96 Sales past 5Y258.65% Gross Margin33.40% 52W Low0.58% ATR (14)0.67
Dividend Ex-Date- Current Ratio6.96 EPS Y/Y TTM-219.30% Oper. Margin-26.03% RSI (14)35.48 Volatility2.40% 2.59%
Employees1184 Debt/Eq0.01 Sales Y/Y TTM-53.27% Profit Margin-58.03% Recom2.67 Target Price26.67
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-435.05% Payout- Rel Volume0.71 Prev Close21.07
Sales Surprise6.31% EPS Surprise197.83% Sales Q/Q4.14% EarningsFeb 28 BMO Avg Volume213.81K Price20.78
SMA20-3.88% SMA50-10.69% SMA200-26.98% Trades Volume151,640 Change-1.38%
Date Action Analyst Rating Change Price Target Change
Dec-07-23Initiated UBS Neutral $35
Dec-08-22Downgrade Piper Sandler Overweight → Neutral $65 → $40
Nov-18-22Initiated Raymond James Outperform $45
Aug-25-22Initiated Credit Suisse Outperform $65
Feb-04-22Resumed Piper Sandler Overweight $80
Aug-05-21Resumed Credit Suisse Underperform $55
Jan-08-21Downgrade Credit Suisse Neutral → Underperform $42 → $40
Nov-24-20Downgrade BTIG Research Buy → Neutral
Aug-20-20Initiated Oppenheimer Outperform $75
May-29-20Initiated BTIG Research Buy $20
Apr-11-24 04:05PM
Feb-29-24 09:31AM
Feb-28-24 10:18PM
08:00AM Loading…
Feb-13-24 08:00AM
Feb-09-24 08:31AM
Nov-25-23 09:45AM
Nov-14-23 04:30PM
Nov-05-23 09:02AM
Nov-03-23 10:26PM
03:46PM Loading…
Oct-30-23 03:46PM
Oct-25-23 08:00AM
Oct-18-23 09:44AM
Oct-17-23 08:00AM
Aug-05-23 08:56AM
Aug-04-23 10:08PM
Jul-24-23 04:05PM
Jul-18-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 11:40AM
Jun-06-23 07:45AM
Jun-05-23 08:30AM
May-23-23 09:53AM
08:20AM Loading…
May-18-23 04:05PM
May-08-23 11:15AM
May-05-23 08:15AM
Apr-26-23 08:00PM
Apr-20-23 04:05PM
Apr-16-23 02:01PM
Apr-14-23 07:13AM
Apr-12-23 09:40AM
Apr-11-23 08:00AM
Mar-27-23 09:40AM
Mar-24-23 03:54PM
Mar-09-23 09:40AM
Mar-04-23 07:50AM
Mar-03-23 11:17AM
Mar-01-23 10:13AM
Feb-28-23 08:25PM
Feb-26-23 09:05AM
Feb-23-23 04:05PM
Feb-14-23 04:05PM
Feb-03-23 05:18AM
Jan-03-23 04:05PM
Dec-15-22 08:11AM
Dec-02-22 12:08PM
Nov-24-22 10:30AM
Nov-17-22 04:05PM
Nov-16-22 06:52AM
Nov-09-22 08:02AM
Nov-07-22 05:55PM
Oct-26-22 07:54AM
Oct-25-22 04:03PM
Oct-20-22 04:03PM
Oct-10-22 11:31AM
Aug-26-22 07:22AM
Aug-25-22 12:10PM
Aug-23-22 02:03PM
Aug-06-22 05:00AM
Aug-05-22 06:30AM
Aug-04-22 07:25PM
Jul-25-22 06:15PM
Jul-19-22 08:00AM
Jul-14-22 06:17PM
Jul-11-22 09:46AM
Jul-05-22 08:00AM
Jun-29-22 06:15PM
Jun-21-22 06:15PM
Jun-19-22 09:06AM
Jun-04-22 08:06AM
May-19-22 07:04AM
May-17-22 11:30AM
May-03-22 11:30PM
Apr-28-22 10:15AM
Apr-27-22 12:05PM
Apr-25-22 06:05PM
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Xie JianPresident and COODec 11 '23Sale26.5222,000583,453363,124Dec 13 08:49 PM
Xie JianPresident and COODec 04 '23Sale27.571,77949,053385,124Dec 06 06:00 PM
Gao HanlinChief Scientific OfficerDec 04 '23Sale27.571,43739,623905,882Dec 06 05:47 PM
Kim PaulCFO and TreasurerDec 04 '23Sale27.571,43739,623200,460Dec 06 05:54 PM
Xie JianPresident and COONov 16 '23Sale27.251,61744,065386,903Nov 20 04:30 PM
Kim PaulCFO and TreasurerNov 16 '23Sale27.251,30735,617201,897Nov 20 04:27 PM
Xie JianPresident and COOSep 07 '23Sale31.411,49246,861416,022Sep 11 04:37 PM
Kim PaulCFO and TreasurerSep 07 '23Sale31.411,49246,861214,061Sep 11 04:35 PM
Gao HanlinChief Scientific OfficerSep 07 '23Sale31.411,04132,696912,932Sep 11 04:34 PM
Kim PaulCFO and TreasurerAug 28 '23Sale33.6210,299346,297215,553Aug 30 04:54 PM
Kim PaulCFO and TreasurerAug 17 '23Sale33.881,79860,918225,852Aug 21 04:40 PM
Xie JianPresident and COOAug 17 '23Sale33.881,30744,283417,514Aug 21 04:43 PM
Gao HanlinChief Scientific OfficerAug 17 '23Sale33.8834211,587913,973Aug 21 04:34 PM
Xie JianPresident and COOJun 02 '23Sale40.301,43357,744425,794Jun 06 05:11 PM
Kim PaulCFO and TreasurerJun 02 '23Sale40.301,40356,535228,890Jun 06 05:09 PM
Gao HanlinChief Scientific OfficerJun 02 '23Sale40.301,00040,296914,391Jun 06 05:06 PM
Xie JianPresident and COOMay 17 '23Sale35.461,32046,810427,227May 19 04:23 PM
Kim PaulCFO and TreasurerMay 17 '23Sale35.461,26644,895230,293May 19 04:19 PM
Gao HanlinChief Scientific OfficerMay 17 '23Sale35.4634512,234915,391May 19 04:15 PM